Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Szegezdi

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|October 5, 2020
Editorial: Death Receptors, Non-apoptotic Signaling Pathways and InflammationEva Szegezdi, Patrick Legembre
The Journal of Investigative Dermatology|January 24, 2016
Guiding the Killer and Bringing in Accomplices: Bispecific Antibody Treatment for Malignant MelanomaEva Szegezdi, Martin Leverkus
Bio-Protocol|August 30, 2021
Generation of Tumour-stroma Minispheroids for Drug Efficacy TestingMark Watters, Eva Szegezdi
Cancers|October 27, 2022
TRAIL in the Treatment of Cancer: From Soluble Cytokine to NanosystemsHojjat Alizadeh Zeinabad, Eva Szegezdi
Oncoscience|December 24, 2015
An added dimension to tumour TRAIL sensitivitySandra Healy, Lynda O'Leary, Eva Szegezdi
Annals of the New York Academy of Sciences|March 23, 2004
Caspase-12 and ER-stress-mediated apoptosis: the story so farEva Szegezdi, Una Fitzgerald, Afshin Samali
Apoptosis : an International Journal on Programmed Cell Death|July 21, 2025
Disrupting membranes, controlling cell fate: the role of pore-forming proteins in cell death and therapySonia Iranpour, Maryam Arif, Eva Szegezdi
Blood Reviews|May 29, 2021
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunitiesEimear O'Reilly, Hojjat Alizadeh Zeinabad, Eva Szegezdi
Bioinformatics Advances|September 28, 2023
CCPlotR: an R package for the visualization of cell-cell interactionsSarah Ennis, Pilib Ó Broin, Eva Szegezdi
Annals of the New York Academy of Sciences|September 3, 2009
Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance?Amandine Plantivaux, Eva Szegezdi, Afshin Samali, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|October 5, 2020
Editorial: Death Receptors, Non-apoptotic Signaling Pathways and InflammationEva Szegezdi, Patrick Legembre
The Journal of Investigative Dermatology|January 24, 2016
Guiding the Killer and Bringing in Accomplices: Bispecific Antibody Treatment for Malignant MelanomaEva Szegezdi, Martin Leverkus
Bio-Protocol|August 30, 2021
Generation of Tumour-stroma Minispheroids for Drug Efficacy TestingMark Watters, Eva Szegezdi
Cancers|October 27, 2022
TRAIL in the Treatment of Cancer: From Soluble Cytokine to NanosystemsHojjat Alizadeh Zeinabad, Eva Szegezdi
Oncoscience|December 24, 2015
An added dimension to tumour TRAIL sensitivitySandra Healy, Lynda O'Leary, Eva Szegezdi
Annals of the New York Academy of Sciences|March 23, 2004
Caspase-12 and ER-stress-mediated apoptosis: the story so farEva Szegezdi, Una Fitzgerald, Afshin Samali
Apoptosis : an International Journal on Programmed Cell Death|July 21, 2025
Disrupting membranes, controlling cell fate: the role of pore-forming proteins in cell death and therapySonia Iranpour, Maryam Arif, Eva Szegezdi
Blood Reviews|May 29, 2021
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunitiesEimear O'Reilly, Hojjat Alizadeh Zeinabad, Eva Szegezdi
Bioinformatics Advances|September 28, 2023
CCPlotR: an R package for the visualization of cell-cell interactionsSarah Ennis, Pilib Ó Broin, Eva Szegezdi
Annals of the New York Academy of Sciences|September 3, 2009
Is there a role for nuclear factor kappaB in tumor necrosis factor-related apoptosis-inducing ligand resistance?Amandine Plantivaux, Eva Szegezdi, Afshin Samali, et al.
Pageof 7